Ghp Investment Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Ghp Investment Advisors, Inc.

$2.15 Billion
Q3 2024

A detailed history of Ghp Investment Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 32,065 shares of TEVA stock, worth $526,827. This represents 0.03% of its overall portfolio holdings.

Number of Shares

32,065

Previous 1,800 1681.39%

Holding current value

$526,827

Previous $29,000 1889.66%

% of portfolio

0.03%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$15.81 - $18.96 $478,489 - $573,824	30,265 Added 1681.39%	32,065 $577,000
Q1 2024 Apr 25, 2024	SELL	$10.67 - $14.43 $2,134 - $2,886	-200 Reduced 10.0%	1,800 $25,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $2,880 - $3,788	-400 Reduced 16.67%	2,000 $15,000
Q1 2022 Apr 28, 2022	BUY	$7.33 - $9.39 $17,592 - $22,536	2,400 New	2,400 $23,000
Q2 2019 Aug 02, 2019	SELL	$8.12 - $15.72 $211,306 - $409,081	-26,023 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $66,994 - $86,043	4,300 Added 19.79%	26,023 $408,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $2,918 - $4,768	-200 Reduced 0.91%	21,723 $335,000
Q3 2018 Oct 17, 2018	BUY	$21.06 - $25.65 $13,057 - $15,903	620 Added 2.91%	21,923 $472,000
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $87,032 - $148,025	7,750 Added 57.18%	21,303 $404,000
Q3 2017 Nov 03, 2017	BUY	$15.41 - $32.17 $208,851 - $436,000	13,553	13,553 $239,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.

Account

Ghp Investment Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History